Violette Shelia M.
Violette Shelia M., CSO, reported an open-market or private sale at Q32 Bio Inc. involving 917.000000 shares for an estimated $7629.16. Reported holdings after the transaction were 126854.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 06, 2026
- Filing date
- Oct 14, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 127,771 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingQTTB price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-421835 Common Stock
- Transaction date
- Oct 06, 2026 Filed Oct 14, 2026, 09:30 PM · 8d delay
- Shares
- 917 sh $8.32 per share
- Estimated value
- -$7.62k Computed from shares × price
- Holdings after
- 126,854 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - delayed_filing-6 points
reporting_delay_days = 8
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Scientific Officer
- F1
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units. These sales were automati…
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.07 to $8.32. The Reporting Person undertakes to provide to the Issue…
- F3
Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuni…
0 other transactions
0 recent txs